User: Genecampaign Topic: IP
Category: patents :: everywhere
1 new since Apr 20 2018 13:53 IST RSS 2.0
 
7,454 to 7,473 of 11,153    
Life-saving drugs to get cheaper 7.7.2009 HBL: Industry & Economy
New Delhi, July 6 Heart patients and those with diseases such as breast cancer, hepatitis-B and rheumatic arthritis will get cheaper drugs as the Government has announced a reduction on Customs duty on 10 specific life-saving drugs.
Also found in: [+]
(!) ZIMBLEE, a Do-it-Yourself Platform, revolutionizes online display advertising 6.7.2009 Financial Express
(!) ZIMBLEE, a Do-it-Yourself Platform, revolutionizes online display advertising
Also found in: [+]
An invention that could save million of gallons of fuel every day 6.7.2009 New Kerala: World News
Also found in: [+]
An invention that could save million of gallons of fuel every day 6.7.2009 New Kerala: World News
Also found in: [+]
Fake drugs reach Kenya now 6.7.2009 ET: Foreign Trade
Kenyan govt seized two container loads of medicines shipped from Shanghai bearing a 'government of Kenya' label falsely indicating that it was manufactured in Kenya.
Also found in: [+]
EIE - the new age multi-utility course 6.7.2009 Hindu:Education Plus: Hyderabad
Experts advise students to go for the hybrid course, which offers a plethora of opportunities in India and abroad, writes G. RAVIKIRAN
Also found in: [+]
Award for Shankar Netralaya founder 5.7.2009 New Indian Express
Award for Shankar Netralaya founder
Also found in: [+]
Novartis loses battle for cancer drug patent 5.7.2009 Rediff: Business
Novartis's famed cancer drug, Glivec, will not get patent protection in India. The apex body on patent and trademark disputes, the Intellectual Property Appellate Board (IPAB), has ruled that the drug "lacks innovation" and the high price tag of Rs 120,000 per month per patient would be too high for the common man.
Also found in: [+]
'Novartis' cancer drug is not patentable' 5.7.2009 Sify Finance
The Intellectual Property Appellate Board (IPAB) has said that Novartis' cancer drug Glivec (Imatinib Mesylate) is not patentable in the beta crystalline form.
Also found in: [+]
Novartis’ cancer drug denied patent in India 5.7.2009 Financial Express
Novartis’ cancer drug denied patent in India
Also found in: [+]
Illegal detention of minor costs Gujarat cops 5.7.2009 The Statesman
Illegal detention of minor costs Gujarat cops
Also found in: [+]
Novartis’ cancer drug is not patentable, says appellate board 5.7.2009 HBL: Corporate
Mumbai, July 4 The Intellectual Property Appellate Board (IPAB) has said that Novartis’ cancer drug Glivec (Imatinib Mesylate) is not patentable in the beta crystalline form.
Also found in: [+]
Beware of ‘gene giants,’ farmers told 4.7.2009 Hindu: Kerala
Bio-pirates on the prowl to secure patents on Pokkali: Vandana Shiva
Also found in: [+]
Biotechnology can be the next big driver for the pharma sector 3.7.2009 DNA: Top News
The coming together of Biocon and Mylan for a biogenerics entry coincided with a study done by EvaluatePharma.
Also found in: [+]
Mamata prefers jhola to carry budget papers 3.7.2009 New Indian Express
Mamata prefers jhola to carry budget papers
Also found in: [+]
Mamata carries railway budget papers in jhola 3.7.2009 DNA: Top News
Also, the car in which she came was her personal Maruti Zen rather than the official vehicle she has chosen not to take from the government.
Also found in: [+]
Mamata prefers 'jhola' to carry railway budget papers 3.7.2009 Hindu: Breaking News
Mamata prefers 'jhola' to carry railway budget papers
Also found in: [+]
Mamata prefers 'jhola' to carry rly budget papers 3.7.2009 HBL: Breaking News
Mamata prefers 'jhola' to carry rly budget papers
Also found in: [+]
Mamata prefers jhola to carry Rail Budget papers 3.7.2009 Rediff: Business
It was the humble 'jhola' rather than the traditional leather briefcase Railway Minister Mamata Banerjee preferred to bring her budget papers to Parliament on Friday.
Also found in: [+]
Glenmark gets first-to-file status for 3 drugs in US 3.7.2009 ET: Pharma
Glenmark Pharmaceuticals has received first-to-file status for three of its abbreviated new drug applications (ANDA) that have a combined revenue of over $2 billion (about Rs 9,600 crore at current exchange rates) in the US.
Also found in: [+]
7,454 to 7,473 of 11,153